ESC 365 - The impact of serum amolyoid A on long term mortality (12 years) in patients with carotid atherosclerosis.

ESC Premium Access

The impact of serum amolyoid A on long term mortality (12 years) in patients with carotid atherosclerosis.

Session: Integration of old and new prognostic biomarkers in patients with cardiovascular disease

Topic: Biomarkers

Speaker: Associate Professor M. Hoke (Vienna, AT)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Matthias Hoke

Medical University of Vienna, Vienna (Austria)

0 follower

4 more presentations in this session

State of the art: integration of old and new prognostic biomarkers in patients with cardiovascular disease

Speaker: Professor M. Kavousi (Rotterdam, NL)

Iron deficiency independently and strongly predicts adverse outcome in patients with acute coronary syndrome - first report on the prospective relevance of iron deficiency

Speaker: Doctor S. Schaefer (Hamburg, DE)

Relation of gut microbiota-dependent TMAO with aortic atherosclerosis: prognostic implication for patients with stroke

Speaker: Doctor A. Haghikia (Bochum, DE)

Evidence-based medicine: challenges in implementation of new prognostic tools.

Speaker: Professor M. Piepoli (San Donato Milanese, IT)

Access the full session

Integration of old and new prognostic biomarkers in patients with cardiovascular disease

Speakers: Associate Professor M. Hoke, Professor M. Kavousi, Doctor S. Schaefer, Doctor A. Haghikia, Professor M. Piepoli

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources